MALFITANO, Anna Maria
 Distribuzione geografica
Continente #
NA - Nord America 3.457
AS - Asia 3.307
EU - Europa 2.181
SA - Sud America 352
Continente sconosciuto - Info sul continente non disponibili 189
AF - Africa 75
OC - Oceania 3
Totale 9.564
Nazione #
US - Stati Uniti d'America 3.341
SG - Singapore 1.445
RU - Federazione Russa 1.077
VN - Vietnam 642
CN - Cina 546
IT - Italia 467
BR - Brasile 279
HK - Hong Kong 277
DE - Germania 125
FR - Francia 109
GB - Regno Unito 93
BD - Bangladesh 92
IN - India 68
NL - Olanda 67
CA - Canada 56
JP - Giappone 55
FI - Finlandia 49
UA - Ucraina 46
SE - Svezia 35
MX - Messico 34
AR - Argentina 32
KR - Corea 25
IE - Irlanda 24
PL - Polonia 24
IQ - Iraq 23
TH - Thailandia 19
ZA - Sudafrica 17
ES - Italia 16
PH - Filippine 16
TW - Taiwan 14
ID - Indonesia 13
EC - Ecuador 11
PK - Pakistan 11
CI - Costa d'Avorio 9
CO - Colombia 8
TN - Tunisia 8
IL - Israele 7
MA - Marocco 7
TR - Turchia 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
EG - Egitto 6
LT - Lituania 6
SN - Senegal 6
AT - Austria 5
CL - Cile 5
JO - Giordania 5
UZ - Uzbekistan 5
ET - Etiopia 4
MR - Mauritania 4
OM - Oman 4
SA - Arabia Saudita 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
DZ - Algeria 3
GT - Guatemala 3
IR - Iran 3
JM - Giamaica 3
MY - Malesia 3
PE - Perù 3
PR - Porto Rico 3
PS - Palestinian Territory 3
RO - Romania 3
TT - Trinidad e Tobago 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BE - Belgio 2
BZ - Belize 2
CH - Svizzera 2
CY - Cipro 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
KW - Kuwait 2
LU - Lussemburgo 2
MK - Macedonia 2
PT - Portogallo 2
PY - Paraguay 2
SV - El Salvador 2
TL - Timor Orientale 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BS - Bahamas 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CU - Cuba 1
GE - Georgia 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
ML - Mali 1
Totale 9.361
Città #
Singapore 649
San Jose 561
Chandler 353
Ashburn 345
Hong Kong 263
Moscow 232
Beijing 184
Naples 176
Ho Chi Minh City 165
Hanoi 138
Santa Clara 98
Los Angeles 89
Council Bluffs 85
Millbury 82
Hefei 70
Lauterbourg 70
The Dalles 69
Lawrence 57
Amsterdam 54
Phoenix 52
Tokyo 50
Boston 49
New York 43
Dallas 41
Rome 40
Munich 39
Napoli 38
Des Moines 37
São Paulo 37
Redondo Beach 34
Buffalo 33
Wilmington 31
Haiphong 29
Da Nang 28
Orem 26
Nanjing 24
Denver 19
Frankfurt am Main 18
Helsinki 18
Princeton 18
Warsaw 18
Brooklyn 17
Jacksonville 17
Atlanta 16
Houston 16
Turku 16
Mexico City 15
Ottawa 14
Poplar 14
Rio de Janeiro 14
Chicago 13
Seoul 13
Dong Ket 12
San Francisco 12
Seattle 12
Stockholm 12
Changsha 11
Hebei 11
Hải Dương 11
Washington 11
Ann Arbor 10
Chennai 10
Montreal 10
Bangkok 9
London 9
New Delhi 9
Shanghai 9
Turin 9
Baghdad 8
Falkenstein 8
Biên Hòa 7
Bắc Ninh 7
Can Tho 7
Nanchang 7
Pune 7
Salvador 7
Tianjin 7
Brasília 6
Charlotte 6
Dakar 6
Dhaka 6
Dublin 6
Florence 6
Guayaquil 6
Jiaxing 6
Johannesburg 6
Madrid 6
Milan 6
Nuremberg 6
Philadelphia 6
Phủ Lý 6
Amman 5
Augusta 5
Belo Horizonte 5
Bengaluru 5
Curitiba 5
Jakarta 5
Kochi 5
Long Xuyen 5
Miami 5
Totale 4.988
Nome #
A comparative study of the effects of platinum (Ii) complexes on β-amyloid aggregation: Potential neurodrug applications 228
Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer 208
Impaired Seroconversion After Severe Acute Respiratory Syndrome Coronavirus 2 mRNA Vaccine in Patients With Thymic Epithelial Tumors 207
Nucleophosmin-1 regions associated with acute myeloid leukemia interact differently with lipid membranes 170
Glucosyl Platinum(II) Complexes Inhibit Aggregation of the C-Terminal Region of the Aβ Peptide 159
G-Quadruplex Binders Induce Immunogenic Cell Death Markers in Aggressive Breast Cancer Cells 155
Platinum(II) O,S Complexes Inhibit the Aggregation of Amyloid Model Systems 154
Structural insights into amyloid structures of the C-terminal region of nucleophosmin 1 in type A mutation of acute myeloid leukemia 153
Cannabidiol: State of the art and new challenges for therapeutic applications 152
The Cannabinoid CB1 Receptor Antagonist Rimonabant (SR141716) Inhibits Human Breast Cancer Cell Proliferation through a Lipid Raft-Mediated Mechanism 150
Anandamide inhibits adhesion and migration of breast cancer cells. 145
The CB1 receptor antagonist rimonabant controls cell viability and ascitic tumour growth in mice. 145
The oncolytic virus dl922-947 triggers immunogenic cell death in mesothelioma and reduces Xenograft growth 144
Virotherapy: From single agents to combinatorial treatments 144
Combination of dl922-947 Oncolytic Adenovirus and G-Quadruplex Binders Uncovers Improved Antitumor Activity in Breast Cancer 140
Characterization of linear mimetic peptides of Interleukin-22 from dissection of protein interfaces 137
1,2-Dihydro-2-oxopyridine-3-carboxamides: The C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor 133
Immunomodulatory properties of 1,2-dihydro-4-hydroxy-2-oxo-1,8-naphthyridine-3-carboxamide derivative VL15 132
Endocannabinoid System in Neurological Disorders 131
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity 130
N6-isopentenyladenosine affects cytotoxic activity and cytokines production by IL-2 activated NK cells and exerts topical anti-inflammatory activity in mice 129
Conformational consequences of NPM1 rare mutations: An aggregation perspective in Acute Myeloid Leukemia 126
p53 regulates the mevalonate pathway in human glioblastoma multiforme 125
Structures and micelle locations of the nonlipidated and lipidated C-terminal membrane anchor of 2’,3’-cyclic nucleotide-3’-phosphodiesterase 124
Self-assembly of bio-inspired heterochiral peptides 124
Interaction of endocannabinoid system and steroid hormones in the control of colon cancer cell growth 123
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells 123
Immunological signature of patients with thymic epithelial tumors and Good syndrome 123
Pharmacological inhibition of wee1 potentiates the antitumoral effect of the dl922-947 oncolytic virus in malignant mesothelioma cell lines 122
Small molecules enhancers of amyloid aggregation of C-terminal domain of Nucleophosmin 1 in acute myeloid leukemia 121
N6-isopentenyladenosine, an endogenous isoprenoid end product, directly affects cytotoxic and regulatory functions of human NK cells through FDPS modulation 121
Insights into Network of Hot Spots of Aggregation in Nucleophosmin 1 120
Anandamide inhibits endothelial cell proliferation in vitro and angiogenesis in vivo 120
Immuno-Modulatory and Anti-Inflammatory Effects of Dihydrogracilin A, a Terpene Derived from the Marine Sponge Dendrilla membranosa 120
Inhibition of HMG-CoA reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cell. 118
What we know and do not know about the cannabinoid receptor 2 (CB2) 118
Pharmacological actions of statins: A critical appraisal in the management of cancer 118
Nutritional bioactive compounds with beneficial effects for multiple sclerosis: Potential implication of G-Quadruplexes? 116
N6-isopentenyladenosine improves nuclear shape in fibroblasts from humans with progeroid syndromes by inhibiting the farnesylation of prelamin A. 116
Update on the endocannabinoid system as an anticancer target 116
Effects on immune cells of a new 1,8-naphthyridin-2-one derivative and its analogues as selective CB2 agonists: implications in multiple sclerosis 115
ONCOLYTIC VIRUSES AS A POSSIBLETHERAPEUTIC STRATEGY AGANIST MALIGNANT PLEURAL MESOTHELIOMA 115
Anandamide inhibits the Wnt/β-catenin signalling pathway in human breast cancer MDA MB 231 cells 114
The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach. 114
Targeting G-quadruplex motifs interferes with differentiation of adipose-derived mesenchymal stem cells 113
Synergistic inhibition of human colon cancer cell growth by the cannabinoid CB1 receptor antagonist rimonabant and oxaliplatin 112
Immune-Modulation and Properties of Absorption and Blood Brain Barrier Permeability of 1,8-Naphthyridine Derivatives 112
Virotherapy as a potential therapeutic approach for the treatment of aggressive thyroid cancer 111
Reply to the letter to the editor "Long-term cannabinoid receptor (CB1) blockade in obesity: implications for the development of colorectal cancer" 111
Rimonabant inhibits human colon cancer cell growth and reduces the formation of precancerous lesions in the mouse colon 109
Proteostasis unbalance of nucleophosmin 1 in Acute Myeloid Leukemia: An aggregomic perspective 109
Reply to comment on “Malfitano, A.M. et al. virotherapy as a potential therapeutic approach for the treatment of aggressive thyroid cancer” cancers 2019, 11, 1532 109
Tumor-associated macrophage status in cancer treatment 109
Metal-Complexes Bearing Releasable CO Differently Modulate Amyloid Aggregation 108
Statins in neurological disorders: an overview and update 107
Rimonabant (SR141716) exerts anti-proliferative and immunomodulatory effects in human peripheral blood mononuclear cells 105
Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation 103
Oxylipins from Dracontium loretense 100
Use of cannabinoid receptor agonists in cancer therapy as palliative and curative agents 99
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response 98
Potential therapeutic role of statins in neurological disorders 96
Immuno-Modulatory Properties of a Quinolin-2-(1H)-on-3-Carboxamide Derivative: Relevance in Multiple Sclerosis 95
Cross talk of macrophages with tumor microenvironment cells and modulation of macrophages in cancer by virotherapy 92
Biological and pharmacological roles of N6-isopentenyladenosine: an emerging anticancer drug 87
The anandamide analogue, Met-F-AEA, controls human breast cancer cell migration via the RhoA/Rho kinase signaling pathway 85
Arvanil inhibits T lymphocyte activation and ameliorates autoimmune encephalomyelitis 82
Comment on “the negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia.” 82
Breast adiponcosis: a call for further research 78
Arvanil and anandamide up-regulate CD36 expression in human peripheral blood mononuclear cells 78
Interactions of cisplatin analogues with lysozyme: a comparative analysis 72
The Diet-Multiple Sclerosis Connection: Oxidative Stress and Emerging Mechanisms 70
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold 67
Endocannabinoids in endocrine and related tumours 67
N(6)-isopentenyladenosine inhibits cell proliferation and induces apoptosis in a human colon cancer cell line DLD1 65
Molecular signaling involving intrinsically disordered proteins in prostate cancer 62
Cannabinoid receptor CB1 antagonists state of the art and challenges 62
Phytocannabinoids and cannabimimetic drugs: Recent patents in central nervous system disorders 61
History of how viruses can fight cancer: From the miraculous healings to the approval of oncolytic viruses 59
Helicobacter pylori has stimulatory effects on naive T cells 59
Cannabinoids in the management of spasticity associated with multiple sclerosis 58
Rimonabant reduces keratinocyte viability by induction of apoptosis and exerts topical anti-inflammatory activity in mice 56
From anecdotal evidence of cannabinoids in multiple sclerosis to emerging new therapeutical approaches 54
Editorial (Thematic Issue: From Old Cannabinoids to Emerging New Synthetic Derivatives with Potential Therapeutic Application in Neurological Disorders) 53
The N-Terminal Domain of 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase Harbors a GTP/ATP Binding Site 52
Involvement of Akt/NF-κB pathway in N6-isopentenyladenosine-induced apoptosis in human breast cancer cells 50
From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases 48
null 35
Peptidomimetics Targeting the Amyloidogenicity of Nucleophosmin 1 Mutations in Acute Myeloid Leukemia 21
SAHA induces immunogenic cell death in triple negative breast cancer cells and its efficacy is enhanced by SOCS3 functional replacement 5
Totale 9.564
Categoria #
all - tutte 34.402
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.402


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022520 0 0 0 3 2 18 13 19 53 100 123 189
2022/2023737 89 103 6 74 93 75 1 72 129 47 42 6
2023/2024469 12 80 119 33 27 60 9 19 5 13 70 22
2024/20252.214 111 80 4 12 59 115 257 140 120 285 839 192
2025/20264.648 401 328 458 507 842 213 509 207 598 302 154 129
2026/2027501 114 152 227 8 0 0 0 0 0 0 0 0
Totale 9.564